VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | -15.7% | 8,544 | +18.8% | 0.00% | -33.3% |
| Q2 2023 | $134 | +54.0% | 7,194 | +18.9% | 0.00% | +50.0% |
| Q1 2023 | $87 | -19.4% | 6,050 | +7.8% | 0.00% | 0.0% |
| Q4 2022 | $108 | -100.0% | 5,610 | -59.1% | 0.00% | -84.6% |
| Q3 2022 | $471,000 | +970.5% | 13,719 | +373.1% | 0.01% | +1200.0% |
| Q2 2022 | $44,000 | -4.3% | 2,900 | +42.2% | 0.00% | 0.0% |
| Q1 2022 | $46,000 | – | 2,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 22,366 | $311,782 | 0.22% |